{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:16:46Z","timestamp":1794543406710,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ijantimicag.2022.106529","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T16:26:30Z","timestamp":1642436790000},"page":"106529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Erdosteine enhances antibiotic activity against bacteria within biofilm"],"prefix":"10.1016","volume":"59","author":[{"given":"Arianna","family":"Pani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Lucini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Dugnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Scaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2022.106529_bib0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcma.2017.07.012","article-title":"Bacterial biofilm and associated infections","volume":"81","author":"Jamal","year":"2018","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ijos.2014.65","article-title":"Strategies for combating bacterial biofilm infections","volume":"7","author":"Wu","year":"2015","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0003","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrd1008","article-title":"Understanding biofilm resistance to antibacterial agents","volume":"2","author":"Davies","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0004","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1086\/323130","article-title":"Device-associated infections: a macroproblem that starts with microadherence","volume":"33","author":"Darouiche","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200666010-00001","article-title":"Optimising dosing strategies of antibacterials utilising pharmacodynamic principles: impact on the development of resistance","volume":"66","author":"DeRyke","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0006","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/21505594.2017.1313372","article-title":"Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action","volume":"9","author":"Roy","year":"2018","journal-title":"Virulence"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0007","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3389\/fmicb.2020.00952","article-title":"Innovative strategies toward the disassembly of the EPS matrix in bacterial biofilms","volume":"11","author":"Pinto","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0008","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.phrs.2006.12.006","article-title":"An overview of erdosteine antioxidant activity in experimental research","volume":"55","author":"Moretti","year":"2007","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0009","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pupt.2018.10.005","article-title":"Erdosteine: drug exhibiting polypharmacy for the treatment of respiratory diseases","volume":"53","author":"Dal Negro","year":"2018","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0010","first-page":"75","article-title":"The combination of the SH metabolite of erdosteine (a mucoactive drug) and ciprofloxacin increases the inhibition of bacterial adhesiveness achieved by ciprofloxacin alone","volume":"28","author":"Dal Sasso","year":"2002","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0011","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000063223","article-title":"Bacterial adhesiveness: effects of the SH metabolite of erdosteine (mucoactive drug) plus clarithromycin versus clarithromycin alone","volume":"47","author":"Braga","year":"2001","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0012","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1600-0773.2003.920407.x","article-title":"Depressant effects of ambroxol and erdosteine on cytokine synthesis, granule enzyme release, and free radical production in rat alveolar macrophages activated by lipopolysaccharide","volume":"92","author":"Jang","year":"2003","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0013","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tox.2006.08.027","article-title":"Regulation of sepsis-induced apoptosis of pulmonary cells by posttreatment of erdosteine and N-acetylcysteine","volume":"228","author":"Demiralay","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0014","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s10753-016-0393-4","article-title":"Anti-inflammatory effect of erdosteine in lipopolysaccharide-stimulated RAW 264.7 cells","volume":"39","author":"Park","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0015","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1164\/ajrccm.153.2.8564092","article-title":"Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma","volume":"153","author":"Keatings","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0016","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pupt.2007.07.004","article-title":"Changes in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: a controlled study in current smokers with mild COPD","volume":"21","author":"Dal Negro","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0017","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pupt.2016.09.007","article-title":"Erdosteine reduces the exercise-induced oxidative stress in patients with severe COPD: results of a placebo-controlled trial","volume":"41","author":"Dal Negro","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0018","first-page":"143","article-title":"EQUALIFE Study Group. The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study","volume":"30","author":"Moretti","year":"2004","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0019","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00711-2017","article-title":"Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study","volume":"50","author":"Dal Negro","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0020","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.2147\/COPD.S221852","article-title":"Effect of erdosteine on COPD exacerbations in COPD patients with moderate airflow limitation","volume":"14","author":"Calverley","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0021","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/thx.43.8.585","article-title":"Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis","volume":"43","author":"Ricevuti","year":"1988","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0022","first-page":"612","article-title":"Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study)","volume":"33","author":"Marchioni","year":"1995","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0023","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.00181-13","article-title":"A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms","volume":"57","author":"Bauer","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0024","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1586\/17476348.1.3.307","article-title":"Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease","volume":"1","author":"Moretti","year":"2007","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0025","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2016"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0026","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0027","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftw056","article-title":"Penetration barrier contributes to bacterial biofilm-associated resistance against only select antibiotics, and exhibits genus-, strain- and antibiotic-specific differences","volume":"74","author":"Singh","year":"2016","journal-title":"Pathog Dis"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0028","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/AAC.27.4.619","article-title":"Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material","volume":"27","author":"Nickel","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0029","article-title":"Bacterial extracellular polysaccharides in biofilm formation and function","volume":"3","author":"Limoli","year":"2014","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0030","doi-asserted-by":"crossref","first-page":"E6184","DOI":"10.1073\/pnas.1707687114","article-title":"Bifunctionality of a biofilm matrix protein controlled by redox state","volume":"114","author":"Arnaouteli","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0031","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/08927014.2015.1134515","article-title":"Mini-review: Biofilm responses to oxidative stress","volume":"32","author":"Gambino","year":"2016","journal-title":"Biofouling"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0032","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/14787210.2018.1535898","article-title":"Current anti-biofilm strategies and potential of antioxidants in biofilm control","volume":"16","author":"Ong","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0033","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/08927010802660854","article-title":"Effects of phenol and natural phenolic compounds on biofilm formation by Pseudomonas aeruginosa","volume":"25","author":"Jagani","year":"2009","journal-title":"Biofouling"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0034","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1128\/AAC.02919-15","article-title":"Glutathione-disrupted biofilms of clinical Pseudomonas aeruginosa strains exhibit an enhanced antibiotic effect and a novel biofilm transcriptome","volume":"60","author":"Klare","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02000","article-title":"Conditions under which glutathione disrupts the biofilms and improves antibiotic efficacy of both ESKAPE and non-ESKAPE species","volume":"10","author":"Das","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0036","series-title":"Abstracts of the 4th European Congress of Pharmaceutical Sciences","article-title":"Pilot study on erdosteine activity on reduced glutathione (GSH) plasmatic levels in correlation with levels of the mother compound and main metabolite 9N-thioldiglycolylhomocysteine)","author":"Mancini","year":"1998"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0037","series-title":"Abstracts of the Congres Natjonal de Farmacie","article-title":"Pharmacokinetic determinations of bronco-alveolar secretion levels of erdosteine, erdosteine metabolites and GSH in subject treated with this novel cysteine derivative","author":"Silvestro","year":"1998"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0038","series-title":"Abstracts of the 6th International Conference on Bronchoalveolar Lavage","article-title":"Reduced (GSH) and oxidized (GSSG) levels in plasma and BAL of chronic bronchitis patients treated with erdosteine or N-acetylcisteine (NAC)","author":"Mitrea","year":"1998"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0039","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2217\/fmb.14.33","article-title":"Evaluation of different microtiter plate-based methods for the quantitative assessment of Staphylococcus aureus biofilms","volume":"9","author":"Elkhatib","year":"2014","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2015.00001","article-title":"Methicillin resistance and the biofilm phenotype in Staphylococcus aureus","volume":"5","author":"McCarthy","year":"2015","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0041","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/microorganisms8060960","article-title":"Antimicrobial and antibiofilm activities of probiotic lactobacilli on antibiotic-resistant Proteus mirabilis","volume":"8","author":"Shaaban","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijantimicag.2022.106529_bib0042","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/jcmm.13496","article-title":"Probiotic Lactobacillus sp. inhibit growth, biofilm formation and gene expression of caries-inducing Streptococcus mutans","volume":"22","author":"Wasfi","year":"2018","journal-title":"J Cell Mol Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792200019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792200019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:26:45Z","timestamp":1741346805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485792200019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S092485792200019X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106529","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erdosteine enhances antibiotic activity against bacteria within biofilm","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106529"}}